摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

oxalic acid bis(3,4-methylenedioxyanilide) | 303790-92-3

中文名称
——
中文别名
——
英文名称
oxalic acid bis(3,4-methylenedioxyanilide)
英文别名
N,N'-bis(1,3-benzodioxol-5-yl)oxamide
oxalic acid bis(3,4-methylenedioxyanilide)化学式
CAS
303790-92-3
化学式
C16H12N2O6
mdl
——
分子量
328.281
InChiKey
PYXWANNKJGOAPZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    24
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    95.1
  • 氢给体数:
    2
  • 氢受体数:
    6

安全信息

  • 储存条件:
    -20°C

制备方法与用途

WAY-621089是一种活性分子,可用于研究淀粉样蛋白疾病和突触核蛋白病。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    oxalic acid bis(3,4-methylenedioxyanilide)三溴化硼 作用下, 以 二氯甲烷 为溶剂, 反应 4.0h, 以62%的产率得到oxalic acid bis(3,4-dihydroxyanilide)
    参考文献:
    名称:
    [EN] COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES SUCH AS ALZHEIMER'S DISEASE, TYPE 2 DIABETES, AND PARKINSON'S DISEASE
    [FR] COMPOSES, COMPOSITIONS ET PROCEDES DE TRAITEMENT DE MALADIES AMYLOIDES ET DE SYNUCLEINOPATHIES, NOTAMMENT DE LA MALADIE D'ALZHEIMER, DU DIABETE DE TYPE 2 ET DE LA MALADIE DE PARKINSON
    摘要:
    双-和三-二羟基芳基化合物及其亚甲二氧基类似物和药用可接受酯,它们的合成,含有它们的药物组合物,以及它们在治疗淀粉样疾病,特别是Aß淀粉样病变,如阿尔茨海默病中观察到的,IAPP淀粉样病变,如2型糖尿病中观察到的,以及α-突触核病,如帕金森病中观察到的,以及用于制造用于此类治疗的药物。
    公开号:
    WO2003101927A1
  • 作为产物:
    描述:
    草酰氯3,4-亚甲二氧基苯胺吡啶 作用下, 以 二氯甲烷 为溶剂, 反应 0.5h, 以82%的产率得到oxalic acid bis(3,4-methylenedioxyanilide)
    参考文献:
    名称:
    [EN] COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES SUCH AS ALZHEIMER'S DISEASE, TYPE 2 DIABETES, AND PARKINSON'S DISEASE
    [FR] COMPOSES, COMPOSITIONS ET PROCEDES DE TRAITEMENT DE MALADIES AMYLOIDES ET DE SYNUCLEINOPATHIES, NOTAMMENT DE LA MALADIE D'ALZHEIMER, DU DIABETE DE TYPE 2 ET DE LA MALADIE DE PARKINSON
    摘要:
    双-和三-二羟基芳基化合物及其亚甲二氧基类似物和药用可接受酯,它们的合成,含有它们的药物组合物,以及它们在治疗淀粉样疾病,特别是Aß淀粉样病变,如阿尔茨海默病中观察到的,IAPP淀粉样病变,如2型糖尿病中观察到的,以及α-突触核病,如帕金森病中观察到的,以及用于制造用于此类治疗的药物。
    公开号:
    WO2003101927A1
点击查看最新优质反应信息

文献信息

  • Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosis
    申请人:Snow D. Alan
    公开号:US20070225362A1
    公开(公告)日:2007-09-27
    Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of amyloid diseases, especially Aβ amyloidosis, such as observed in Alzheimer's disease, IAPP amyloidosis, such as observed in type 2 diabetes, AA/SAA amyloidosis, such as observed in systemic AA amyloidosis and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.
    双羟基和三羟基芳基化合物及其甲氧基二氧杂环化物和药学上可接受的酯类,它们的合成,含有它们的制药组合物,以及它们在治疗淀粉样疾病,特别是阿尔茨海默病中观察到的Aβ淀粉样变性,IAPP淀粉样变性,例如在2型糖尿病中观察到的AA / SAA淀粉样变性,以及突触蛋白病,例如在帕金森病中观察到的应用,以及用于制造这种治疗药物。
  • Compounds, compositions and methods for the treatment of synucleinopathies
    申请人:Esposito Luke
    公开号:US20070276034A1
    公开(公告)日:2007-11-29
    Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of synucleinopathies, such as Parkinson's disease, and the manufacture of medicaments for such treatment.
    双-和三-二羟基芳基化合物及其亚甲二氧基类似物和药学上可接受的酯,它们的合成,含有它们的制药组合物,以及它们在治疗突触核病,如帕金森病中的应用和制造用于这种治疗的药物。
  • COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES SUCH AS ALZHEIMER'S DISEASE, TYPE 2 DIABETES, AND PARKINSON'S DISEASE
    申请人:Snow Alan D.
    公开号:US20090069432A1
    公开(公告)日:2009-03-12
    Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of amyloid diseases, especially Aβ amyloidosis, such as observed in Alzheimer's disease, IAPP amyloidosis, such as observed in type 2 diabetes, and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.
    双-和三-二羟基芳基化合物及其二氧化甲基类似物和药学上可接受的酯,它们的合成,含有它们的制药组合物,以及它们在治疗淀粉样疾病中的应用,尤其是Aβ淀粉样蛋白病,如阿尔茨海默病,IAPP淀粉样蛋白病,如2型糖尿病,以及突触核病,如帕金森病,和用于制造这种治疗药物。
  • Compounds, compositions and methods for the treatment of inflammatory diseases
    申请人:Sanders J. Virginia
    公开号:US20070208087A1
    公开(公告)日:2007-09-06
    The use of a composition comprising a compound: where R is a C 1 -C 10 alkylene group, in which, when the number of carbon atoms is at least 2, there are optionally 1 or 2 non-adjacent double bonds; 1 to 3 non-adjacent methylene groups are optionally replaced by NR 1 (where R 1 is H, alkyl, or acyl), O, or S; and 1 or 2 methylene groups are optionally replaced by a carbonyl or hydroxymethylene group for the preparation of a medicament or a pharmaceutical for the treatment of inflammatory diseases.
    使用含有化合物的组合物:其中R是C1-C10烷基基团,当碳原子数至少为2时,可以选则1或2个非相邻的双键;1到3个非相邻的亚甲基团可以被NR1(其中R1为H,烷基或酰基)、O或S替换;并且1或2个亚甲基团可以被羰基或羟甲基基团替换,以制备用于治疗炎症性疾病的药物或制剂。
  • Compounds, Compositions and Methods for the Treatment of Amyloid Diseases and Synucleinopathies such as Alzheimer's Disease, Type 2 Diabetes and Parkinson's Disease
    申请人:SNOW Alan D.
    公开号:US20110172239A1
    公开(公告)日:2011-07-14
    Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of amyloid diseases, especially Aβ amyloidosis, such as observed in Alzheimer's disease, IAPP amyloidosis, such as observed in type 2 diabetes, and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.
    双-和三-二羟基芳基化合物及其亚甲二氧基类似物和药学上可接受的酯,它们的合成,含有它们的制药组合物,以及它们在治疗淀粉样疾病,特别是阿尔茨海默病中观察到的Aβ淀粉样蛋白病,IAPP淀粉样蛋白病,如在2型糖尿病中观察到的和突触核蛋白病,如在帕金森病中观察到的用途,以及制造此类治疗药物。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物